The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Transcatheter valve-in-valve implantation for failing prosthetic valves

EuroIntervention 2014;10:900-902. DOI: 10.4244/EIJV10I8A155

Department of Cardiology and Cardiothoracic Surgery, St Thomas’ Hospital, London, United Kingdom
Introduction

Transcatheter aortic valve implantation (TAVI) is now an established alternative treatment for patients with severe calcific aortic stenosis deemed at high risk for conventional surgical aortic valve replacement1. Tens of thousands of procedures have been performed worldwide since the first implant by Cribier in 2002. As the number of procedures continues to increase rapidly, the procedures and devices have evolved, leading to improvements in patient outcomes. Enthusiasm for the technology has translated into increased use in the treatment of failing bioprosthetic valves. This use was first reported by Wenaweser and colleagues in 20072 and offers an alternative to high-risk redo ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Transcatheter mitral valve-in-ring with the Melody prosthesis: a new therapeutic opportunity